ArticleJournal of Cancer2019

Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells.

Huda Salman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.